Atıf İçin Kopyala
Gundogdu A. G., Onder S., Firat P., DOĞAN R.
JOURNAL OF THORACIC DISEASE, cilt.6, sa.6, ss.778-784, 2014 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
6
Sayı:
6
-
Basım Tarihi:
2014
-
Doi Numarası:
10.3978/j.issn.2072-1439.2014.04.35
-
Dergi Adı:
JOURNAL OF THORACIC DISEASE
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.778-784
-
Anahtar Kelimeler:
Lung adenocarcinoma, epidermal growth factor receptor (EGFR), RAS, survival, GROWTH-FACTOR RECEPTOR, ONCOGENE PRODUCT, PROGNOSTIC VALUE, CANCER, EXPRESSION, MUTATIONS, FREQUENT, MARKERS
-
Hacettepe Üniversitesi Adresli:
Evet
Özet
Background: The impacts of epidermal growth factor receptor (EGFR) immunoexpression and RAS immunoexpression on the survival and prognosis of lung adenocarcinoma patients are debated in the literature.